Drugs / nanoxel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03614364 | Sep 2018 → Sep 2022 | salivary duct carcinoma | Samsung Medical Center | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nanoxel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03614364 ↗ |